Choose a section Top Retailers Supplier News OTC Pharmacy New Products Beauty Care
An investigational treatment for a complication of diabetes that often leads to blindness worked better...
While Big Pharma hurdles toward the edge of the patent cliff, some of the latest...
The Food and Drug Administration has approved Mylan’s version of a drug for complications related...
McNeil Consumer Healthcare on Tuesday announced the introduction of Visine tired eye relief, which features...
Pfizer has named Mikael Dolsten as its president for worldwide research and development, the drug...
A subsidiary of generic drug maker Watson Pharmaceuticals has launched a version of a cholesterol-lowering...
Pfizer plans to lay off 6,000 of its workers and reduce manufacturing or cease manufacturing...
A combination of patent expirations and rising levels of debt could put the drug industry’s...
Pfizer and Washington University plan to work together to find new uses for more than...
Pfizer will acquire worldwide rights to a drug for treating pulmonary arterial hypertension, the drug...
Pfizer reported $16.8 billion in revenues for first quarter 2010, a 54% increase over first...
A once-a-day formulation of a Pfizer drug potentially could capture half of the market for...
The Food and Drug Administration has approved a generic anxiety drug made by Actavis, the...
A phase-3 clinical trial found that a pneumococcal disease vaccine was well-tolerated and immunogenic in...
Drug companies stand to lose a lot of money in the coming years, as the...
Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...
An organization representing the generic drug industry is hoping that Congress gives the Food and...
A pill-based anticoagulant drug under development by Pfizer and Bristol-Myers Squibb worked better in reducing...
The Food and Drug Administration has approved a Novo Nordisk treatment for growth hormone disorders,...
It appears that Pfizer has changed its mind a second time about buying Ratiopharm....
Hopes that a drug Soviet scientists created in the 1980s might provide a treatment for...
GlaxoSmithKline has identified more than 5,500 rare diseases it potentially could target as part of...
A Pfizer executive credited with diversifying the company’s portfolio and helping create a joint venture...
An executive from Pfizer has won an award from the Healthcare Businesswomen’s Association, the HBA...
An investigational drug for treating breast cancer will garner sales of more than $1 billion...
